All Ascend Bio Labs products are sold strictly for in vitro and laboratory research by qualified adults. They are not drugs, foods, cosmetics or supplements, are not for human or veterinary use, and have not been evaluated by the FDA.
GLP-3 RT
Price range: $97.00 through $485.00
GLP-3 RT is a synthetic 39-amino-acid triagonist peptide studied for its roles in GIP receptor signaling, GLP-1 receptor signaling, and glucagon receptor activation pathways. A widely characterized compound in metabolic and energy-homeostasis research literature.
GLP-3 RT is a synthetic 39-amino-acid triagonist peptide studied for its roles in GIP receptor signaling, GLP-1 receptor signaling, and glucagon receptor activation pathways. A widely characterized compound in metabolic and energy-homeostasis research literature.
Research use only
GLP-3 RT from Ascend Bio Labs is supplied strictly for in vitro and laboratory research by qualified adults. It is not a drug, food, cosmetic or supplement, it is not for human or veterinary use, and it has not been evaluated by the FDA.
Quality documentation
An independent laboratory Certificate of Analysis (COA) for this product is published on our Ascend Bio Labs COAs page, paired with the product so you can review the purity and assay results before you order.
Browse the full Individual Products category, read how to order or learn more in Ascend BioLabs Education.
| Quantity | 1, 2, 3, 4, 5 |
|---|
Certificate of Analysis for GLP-3 RT
The independent laboratory report(s) below are published for this compound. Click a page to enlarge it, and read the note on each report about which vial strength it covers. See all reports on the Ascend Bio Labs COAs page.
Retatrutide 10 mg
Third-party reportVanguard Laboratory (Olympia, WA, ISO 17025:2017 accredited) · Released 6/12/2026 · Lab ID V260602-23 001
| Chromatographic purity (HPLC-UV/VIS) | 99.58% ± 0.18% |
|---|---|
| Assay (HPLC-UV/VIS) | 10.44 mg |
Tested vial: 10 mg.
Retatrutide 10 mg
Third-party reportFreedom Diagnostics (USA) · Released 3/12/2026 · Accession 2603110186 · Lot: Black Cap
| Purity (HPLC-UV with mass spectrometry) | 99.433% |
|---|---|
| Net peptide content | 11.27 mg |
| Identity | GLP RT |
Tested vial: 10 mg. Second, separate laboratory.
More from Individual Products
5-Amino-1MQ
5-Amino-1MQ is a small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor studied for its roles in NAD+ salvage pathways, methionine cycle and SAM regulation, and adipocyte lipogenesis signaling. A widely characterized compound in metabolic and energy-homeostasis research literature.
AOD-9604
AOD-9604 is a modified C-terminal fragment of human growth hormone (hGH 177-191) studied for its roles in beta-adrenergic receptor signaling, hormone-sensitive lipase activation, and adipocyte lipogenesis pathways. A widely cited compound in metabolic and adipose tissue research literature.
BPC-157
BPC-157 is a synthetic pentadecapeptide derived from a gastric protective protein, studied for its roles in angiogenic signaling, nitric oxide pathway modulation, and growth factor expression. A widely characterized compound in musculoskeletal and gastrointestinal research literature.
Cagrilintide
Cagrilintide is a synthetic long-acting amylin receptor agonist peptide studied for its roles in amylin receptor signaling, satiety pathway modulation, and gastric emptying regulation. A widely characterized compound in energy-homeostasis and appetite-regulation research literature.




Reviews
There are no reviews yet.